[177Lu]3BP-3775

N/A

Report date: 2025/11/20 16:04:54

NME

Base Information

Drug Name[177Lu]3BP-3775

Drug Alias Name[177Lu]3BP-3775177Lu-3B-401177Lu-3BP-3775

ClassificationRadiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Nuclides > Lutetium > 177LuRadiation-emitting products > Radionuclide Drug Conjugates +[4]

Mechanisms of ActionGlucose-Dependent Insulinotropic Polypeptide Receptor modulators

TargetsGlucose-Dependent Insulinotropic Polypeptide Receptor

Therapy Area/IndicationsNeuroendocrine Tumors

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryGermany

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator Companies3B Pharmaceuticals GmbH

China Registration ClassN/A

Develop Information

Active Companies3B Pharmaceuticals GmbH

Inactive CompaniesN/A

Active IndicationsNeuroendocrine Tumors

Inactive IndicationsN/A

Other Information

ATC CodeN/A